Publications by authors named "Daniel Langenegger"

Claim this Profile
K
Kinetic properties of "dual" orexin receptor antagonists at OX1R and OX2R orexin receptors.
Gabrielle E Callander, Morenike Olorunda, Dominique Monna, Edi Schuepbach, Daniel Langenegger

Front Neurosci· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decahydroisoquinoline derivatives as novel non-peptidic, potent and subtype-selective somatostatin sst(3) receptor antagonists.
Thomas Troxler, Konstanze Hurth, Karl-Heinrich Schuh, Philippe Schoeffter, Daniel Langenegger

Bioorg Med Chem Lett· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaction of Fe3(CO)12 with octreotide--chemical, electrochemical and biological investigations.
Ulf-Peter Apfel, Manfred Rudolph, Christina Apfel, Christian Robl, Daniel Langenegger

Dalton Trans· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of novel non-peptidic beta-alanine piperazine amide derivatives and their optimization to achiral, easily accessible, potent and selective somatostatin sst1 receptor antagonists.
Thomas Troxler, Konstanze Hurth, Henri Mattes, Mahavir Prashad, Philippe Schoeffter, Daniel Langenegger

Bioorg Med Chem Lett· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The enantiomer of octreotate binds to all five somatostatin receptors with almost equal micromolar affinity--a comparison with SANDOSTATIN.
James Gardiner, Daniel Langenegger, Daniel Hoyer, Albert K Beck, Raveendra I Mathad

Chem Biodivers· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues.
Eric Biron, Jayanta Chatterjee, Oded Ovadia, Daniel Langenegger, Joseph Brueggen

Angew Chem Int Ed Engl· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Ergoline derivatives as highly potent and selective antagonists at the somatostatin sst 1 receptor.
Thomas Troxler, Albert Enz, Daniel Hoyer, Daniel Langenegger, Peter Neumann

Bioorg Med Chem Lett· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and SAR of potent and selective non-peptide obeline somatostatin sst1 receptor antagonists.
Thomas Troxler, Daniel Hoyer, Daniel Langenegger, Peter Neumann, Paul Pfäffli

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SAR of the arylpiperazine moiety of obeline somatostatin sst1 receptor antagonists.
Konstanze Hurth, Albert Enz, Philipp Floersheim, Conrad Gentsch, Daniel Hoyer, Daniel Langenegger

Bioorg Med Chem Lett· July 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Compensatory changes in the hippocampus of somatostatin knockout mice: upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission.
Maurizio Cammalleri, Davide Cervia, Massimo Dal Monte, Davide Martini, Daniel Langenegger

Eur J Neurosci· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
Davide Cervia, Daniel Langenegger, Edi Schuepbach, Maurizio Cammalleri, Philippe Schoeffter

Neuropharmacology· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices.
Maurizio Cammalleri, Davide Cervia, Daniel Langenegger, Yanqiang Liu, Massimo Dal Monte

Eur J Neurosci· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.
Caroline Nunn, Davide Cervia, Daniel Langenegger, Laurent Tenaillon, Rochdi Bouhelal

Br J Pharmacol· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
Davide Cervia, Caroline Nunn, Dominique Fehlmann, Daniel Langenegger, Edi Schuepbach

Br J Pharmacol· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Agonist properties of putative small-molecule somatostatin sst2 receptor-selective antagonists.
Caroline Nunn, Daniel Langenegger, Konstanze Hurth, Kerstin Schmidt, Dominique Fehlmann

Eur J Pharmacol· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Beta(2)/beta(3)-di- and alpha/beta(3)-tetrapeptide derivatives as potent agonists at somatostatin sst(4) receptors.
Caroline Nunn, Magnus Rueping, Daniel Langenegger, Edi Schuepbach, Thierry Kimmerlin

Naunyn Schmiedebergs Arch Pharmacol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional characterisation of the putative somatostatin sst2 receptor antagonist CYN 154806.
Caroline Nunn, Philippe Schoeffter, Daniel Langenegger, Daniel Hoyer

Naunyn Schmiedebergs Arch Pharmacol· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis